Literature DB >> 23407480

A minimally invasive and simple screening test for detection of pancreatic ductal adenocarcinoma using biomarkers in duodenal juice.

Yasuhisa Mori1, Takao Ohtsuka, Hiroshi Kono, Yosuke Nagayoshi, Noboru Ideno, Teppei Aso, Shingo Kozono, Kenoki Ohuchida, Shunichi Takahata, Masafumi Nakamura, Kazuhiro Mizumoto, Masao Tanaka.   

Abstract

OBJECTIVES: The aim of this study was to establish a minimally invasive and simple screening test for detection of pancreatic ductal adenocarcinoma (PDAC) using duodenal juice (DJ).
METHODS: Duodenal juice was collected prospectively before endoscopic retrograde cholangiopancreatography in 46 patients. A protease inhibitor was not added to the samples collected during the initial 2.5 minutes but was added in the latter 2.5 minutes. Thereafter, secretin was administered intravenously, and DJ was subsequently collected for additional 10 minutes. The sensitivities of carcinoembryonic antigen (CEA), S100 calcium-binding protein P (S100P), and interleukin 8 in DJ and pancreatic juice were assessed.
RESULTS: There were 30 patients with PDAC and 16 with benign lesions. It was possible to collect an adequate amount of DJ without secretin administration. In the PDAC group, CEA concentrations in DJ were significantly higher than those in the benign group, even without the use of a protease inhibitor. S100P levels in DJ in the PDAC group were significantly higher than those in the benign group in the presence of the protease inhibitor.
CONCLUSIONS: Duodenal juice collection during routine upper endoscopy and assessments of CEA and S100P in DJ might become a useful screening test for detection of PDAC.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23407480     DOI: 10.1097/MPA.0b013e3182649979

Source DB:  PubMed          Journal:  Pancreas        ISSN: 0885-3177            Impact factor:   3.327


  8 in total

Review 1.  International consensus on the management of intraductal papillary mucinous neoplasm of the pancreas.

Authors:  Masao Tanaka
Journal:  Ann Transl Med       Date:  2015-11

Review 2.  The Key Role of Calmodulin in KRAS-Driven Adenocarcinomas.

Authors:  Ruth Nussinov; Serena Muratcioglu; Chung-Jung Tsai; Hyunbum Jang; Attila Gursoy; Ozlem Keskin
Journal:  Mol Cancer Res       Date:  2015-06-17       Impact factor: 5.852

Review 3.  Diagnostic strategies for early pancreatic cancer.

Authors:  Keiji Hanada; Akihito Okazaki; Naomichi Hirano; Yoshihiro Izumi; Yuji Teraoka; Juri Ikemoto; Kozue Kanemitsu; Fumiaki Hino; Toshikatsu Fukuda; Shuji Yonehara
Journal:  J Gastroenterol       Date:  2014-12-14       Impact factor: 7.527

Review 4.  Potential prognostic biomarkers in pancreatic juice of resectable pancreatic ductal adenocarcinoma.

Authors:  Shefali Agrawal
Journal:  World J Clin Oncol       Date:  2017-06-10

Review 5.  Proteomic and genomic profiling of pancreatic cancer.

Authors:  Daniel Ansari; William Torén; Qimin Zhou; Dingyuan Hu; Roland Andersson
Journal:  Cell Biol Toxicol       Date:  2019-02-15       Impact factor: 6.691

Review 6.  Early Detection of Pancreatic Cancer: Role of Biomarkers in Pancreatic Fluid Samples.

Authors:  Noboru Ideno; Yasuhisa Mori; Masafumi Nakamura; Takao Ohtsuka
Journal:  Diagnostics (Basel)       Date:  2020-12-06

Review 7.  Early diagnosis of pancreatic cancer: Current trends and concerns.

Authors:  Keiji Hanada; Hironobu Amano; Tomoyuki Abe
Journal:  Ann Gastroenterol Surg       Date:  2017-04-25

8.  An ultrasensitive polydopamine bi-functionalized SERS immunoassay for exosome-based diagnosis and classification of pancreatic cancer.

Authors:  Teng-Da Li; Ren Zhang; Hui Chen; Zhi-Peng Huang; Xin Ye; Hui Wang; An-Mei Deng; Ji-Lie Kong
Journal:  Chem Sci       Date:  2018-05-23       Impact factor: 9.825

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.